Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science's STKE (221)
Abstract

The cyclin-dependent kinases (CDKs) play a key role in cell cycle control, and in this review, we focus on the events that regulate their activities. Emphasis is placed on the CDKs that function during the G 1 phase of the cell cycle and on the CDK inhibitor p27 Kip1 . We discuss how CDK activation relates to two basic concepts of cell cycle regulation: (i) the need for multiple mitogens for the proliferation of nontransformed cells and (ii) the inhibitory effect of high culture density on proliferative capacity. We also describe how Cdk2 modulates the expression of the α subunit of the interleukin-2 receptor in T cells, and address the question of whether p27 Kip1 functions as an activator or inhibitor of the CDKs associated with the D cyclins.

Bibliography

Olashaw, N., & Pledger, W. J. (2002). Paradigms of Growth Control: Relation to Cdk Activation. Science’s STKE, 2002(134).

Authors 2
  1. Nancy Olashaw (first)
  2. W. J. Pledger (additional)
References 194 Referenced 27
  1. 10.1146/annurev.bi.47.070178.003435
  2. 10.1016/0012-1606(65)90005-9
  3. 10.1016/0304-4165(69)90415-2
  4. 10.1016/0014-4827(74)90484-4
  5. 10.1002/jss.400130405
  6. 10.1146/annurev.bi.43.070174.001125
  7. 10.1073/pnas.71.4.1286
  8. 10.1073/pnas.75.6.2839
  9. 10.1073/pnas.74.10.4481
  10. 10.1016/0014-4827(82)90073-8
  11. 10.1073/pnas.76.3.1279
  12. 10.1073/pnas.81.8.2389
  13. 10.1126/science.3523754
  14. 10.1111/j.1600-065X.1982.tb00423.x
  15. 10.1073/pnas.82.12.4055
  16. 10.1016/0092-8674(86)90390-9
  17. 10.1016/S0955-0674(00)00151-4
  18. 10.1101/gad.9.10.1149
  19. M. Ruas, G. Peters, The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378, F115-177 (1998). / Biochim. Biophys. Acta (1998)
  20. E. J. Firpo, A. Koff, M. J. Solomon, J. M. Roberts, Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14, 4889-4901 (1994). / Mol. Cell. Biol. (1994)
  21. 10.1038/372570a0
  22. 10.1091/mbc.6.9.1197
  23. 10.1074/jbc.271.19.11253
  24. 10.1074/jbc.271.31.18337
  25. 10.1128/MCB.16.8.4327
  26. 10.1074/jbc.272.11.7093
  27. 10.1091/mbc.9.8.2081
  28. 10.1073/pnas.95.3.1091
  29. 10.1126/science.272.5263.877
  30. 10.1016/S0092-8674(00)81237-4
  31. 10.1016/S0092-8674(00)81238-6
  32. 10.1016/S0092-8674(00)81239-8
  33. 10.1016/0092-8674(94)90572-X
  34. 10.1016/0092-8674(94)90573-8
  35. 10.1016/0092-8674(94)90257-7
  36. 10.1091/mbc.11.6.2117
  37. 10.1074/jbc.M010189200
  38. P. Michieli, M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, D. Givol, Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391-3395 (1994). / Cancer Res. (1994)
  39. 10.1083/jcb.131.1.235
  40. L. Kivinen, M. Laiho, Ras- and mitogen-activated protein kinase kinase-dependent and -independent pathways in p21Cip1/Waf1 induction by fibroblast growth factor-2, platelet-derived growth factor, and transforming growth factor-β1. Cell Growth Differ. 10, 621-628 (1999). / Cell Growth Differ. (1999)
  41. M. Gorospe, X. Wang, N. J. Holbrook, Functional role of p21 during the cellular response to stress. Gene Expr. 7, 377-385 (1999). / Gene Expr. (1999)
  42. 10.1038/377552a0
  43. 10.1016/0092-8674(95)90039-X
  44. 10.1667/0033-7587(2001)155[0554:PGAIIH]2.0.CO;2
  45. 10.1101/gad.9.6.639
  46. 10.1101/gad.9.6.650
  47. 10.1101/gad.9.15.1831
  48. 10.1073/pnas.93.24.13742
  49. 10.1146/annurev.pharmtox.39.1.295
  50. 10.1126/science.7624798
  51. 10.1126/science.271.5257.1861
  52. 10.1128/MCB.19.2.1190
  53. 10.1101/gad.11.11.1464
  54. 10.1093/emboj/16.17.5334
  55. 10.1006/bbrc.1997.7590
  56. 10.1101/gad.13.9.1181
  57. 10.1038/12013
  58. 10.1016/S0960-9822(99)80290-5
  59. 10.1038/18230
  60. 10.1074/jbc.M010811200
  61. 10.1126/science.1329201
  62. 10.1126/science.1388288
  63. 10.1016/0092-8674(95)90271-6
  64. 10.1093/emboj/17.2.368
  65. 10.1016/S0014-5793(99)00629-8
  66. 10.1038/8984
  67. 10.1038/sj.onc.1201228
  68. 10.1152/ajpcell.1999.277.4.C652
  69. 10.1074/jbc.M001144200
  70. 10.1074/jbc.M101714200
  71. 10.1128/MCB.17.9.5348
  72. 10.1128/MCB.20.16.5947-5959.2000
  73. 10.1128/MCB.21.15.4960-4967.2001
  74. 10.1074/jbc.274.45.32309
  75. 10.1101/gad.13.13.1742
  76. 10.1038/sj.onc.1204245
  77. 10.1128/MCB.20.24.9138-9148.2000
  78. 10.1083/jcb.148.3.543
  79. 10.1038/35008115
  80. J. T. Winston, S. R. Coats, Y. Z. Wang, W. J. Pledger, Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12, 127-134 (1996). / Oncogene (1996)
  81. 10.1074/jbc.272.52.32966
  82. 10.1038/sj.onc.1201105
  83. 10.1128/MCB.17.7.3850
  84. 10.1098/rstb.1996.0020
  85. 10.1016/S1074-7613(00)80388-X
  86. 10.1006/bbrc.1997.7885
  87. 10.1073/pnas.95.26.15406
  88. 10.1074/jbc.M007291200
  89. 10.1016/S0960-9822(01)00065-3
  90. 10.1074/jbc.272.22.14426
  91. 10.1073/pnas.96.11.6199
  92. 10.1128/MCB.20.23.8969-8982.2000
  93. 10.1074/jbc.M003145200
  94. 10.1016/S0092-8674(00)80595-4
  95. 10.1128/MCB.21.10.3534-3546.2001
  96. 10.1016/S0014-5793(01)02113-5
  97. 10.1038/35055073
  98. 10.1016/S0021-9258(18)53587-0
  99. H. Matsushime, D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, J. Y. Kato, D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066-2076 (1994). / Mol. Cell. Biol. (1994)
  100. M. Meyerson, E. Harlow, Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077-2086 (1994). / Mol. Cell. Biol. (1994)
  101. 10.1038/sj.onc.1202575
  102. 10.1016/0092-8674(91)90101-4
  103. 10.1073/pnas.89.20.9910
  104. 10.1091/mbc.4.11.1133
  105. 10.1101/gad.7.5.812
  106. 10.1074/jbc.271.19.11484
  107. J. Filmus, A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, C. J. Conti, Induction of cyclin D1 overexpression by activated ras. Oncogene 9, 3627-3633 (1994). / Oncogene (1994)
  108. 10.1128/MCB.15.7.3654
  109. 10.1101/gad.12.16.2469
  110. 10.1038/386177a0
  111. 10.1016/S0303-7207(01)00439-7
  112. 10.1074/jbc.270.40.23589
  113. 10.1074/jbc.271.34.20608
  114. 10.1101/gad.12.22.3499
  115. 10.1074/jbc.273.45.29864
  116. 10.1074/jbc.274.31.22033
  117. 10.1128/MCB.19.2.1346
  118. 10.1074/jbc.273.11.6190
  119. 10.1101/gad.10.12.1491
  120. 10.1101/gad.13.22.3027
  121. 10.1101/gad.11.8.957
  122. 10.1101/gad.854900
  123. 10.1038/378785a0
  124. 10.1074/jbc.273.21.13150
  125. 10.1074/jbc.275.16.12074
  126. 10.1101/gad.8.1.9
  127. T. J. Soos, H. Kiyokawa, J. S. Yan, M. S. Rubin, A. Giordano, A. DeBlasio, S. Bottega, B. Wong, J. Mendelsohn, A. Koff, Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7, 135-146 (1996). / Cell Growth Differ. (1996)
  128. 10.1074/jbc.272.41.25863
  129. 10.1093/emboj/18.6.1571
  130. 10.1101/gad.8.15.1750
  131. 10.1101/gad.11.7.847
  132. 10.1101/gad.13.12.1501
  133. 10.1128/MCB.19.3.1775
  134. 10.1128/MCB.20.23.8748-8757.2000
  135. 10.1101/gad.813200
  136. 10.1016/0092-8674(95)90385-2
  137. 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F
  138. 10.1038/sj.onc.1204338
  139. 10.1038/35404
  140. 10.1016/S0092-8674(00)80940-X
  141. 10.1038/35410
  142. 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7
  143. 10.1016/0092-8674(94)90405-7
  144. 10.1128/MCB.16.4.1576
  145. 10.1038/sj.onc.1204331
  146. 10.1128/MCB.18.2.753
  147. 10.1128/MCB.21.14.4773-4784.2001
  148. 10.1128/MCB.15.8.4215
  149. 10.1016/S0378-1119(00)00092-5
  150. 10.1016/S0092-8674(00)80625-X
  151. 10.1016/S0092-8674(00)81519-6
  152. J. R. Nevins, Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585-593 (1998). / Cell Growth Differ. (1998)
  153. X. Mayol, J. Garriga, X. Grana, Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11, 801-808 (1995). / Oncogene (1995)
  154. 10.1101/gad.9.11.1340
  155. 10.1073/pnas.93.10.4633
  156. 10.1093/emboj/20.3.422
  157. 10.1074/jbc.M005707200
  158. 10.1101/gad.8.22.2680
  159. 10.1101/gad.8.22.2665
  160. 10.1101/gad.9.7.869
  161. 10.1128/MCB.15.6.3082
  162. 10.1073/pnas.92.6.2403
  163. 10.1101/gad.11.11.1447
  164. 10.1128/MCB.18.9.5380
  165. 10.1016/S0960-9822(99)80086-4
  166. 10.1074/jbc.272.36.22954
  167. 10.1016/S1097-2765(00)00072-1
  168. M. Kiess, R. M. Gill, P. A. Hamel, Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ. 6, 1287-1298 (1995). / Cell Growth Differ. (1995)
  169. X. Mayol, J. Garriga, X. Grana, G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13, 237-246 (1996). / Oncogene (1996)
  170. 10.1016/S0960-9822(02)00515-8
  171. 10.1093/emboj/16.17.5322
  172. 10.1074/jbc.275.9.6337
  173. 10.1101/gad.10.7.851
  174. 10.1093/emboj/17.20.5987
  175. 10.1101/gad.8.15.1772
  176. M. Xu, K. A. Sheppard, C. Y. Peng, A. S. Yee, H. Piwnica-Worms, Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell. Biol. 14, 8420-8431 (1994). / Mol. Cell. Biol. (1994)
  177. 10.1016/0092-8674(94)90582-7
  178. 10.1016/0092-8674(95)90141-8
  179. 10.1101/gad.10.16.1979
  180. 10.1002/j.1460-2075.1996.tb00793.x
  181. 10.1074/jbc.275.5.3158
  182. 10.1074/jbc.M005600200
  183. 10.1016/S0065-2776(08)60756-7
  184. 10.1084/jem.161.6.1593
  185. 10.1074/jbc.M009788200
  186. V. L. Herzberg, K. A. Smith, T cell growth without serum. J. Immunol. 139, 998-1004 (1987). (10.4049/jimmunol.139.4.998) / J. Immunol. (1987)
  187. 10.1074/jbc.M100037200
  188. 10.1111/j.1432-1033.1997.t01-2-00527.x
  189. S. Mohapatra W. J. Pledger unpublished data.
  190. 10.1073/pnas.89.10.4549
  191. 10.1016/0092-8674(91)90038-Z
  192. 10.1101/gad.7.12a.2378
  193. 10.1016/S0898-6568(00)00104-2
  194. 10.1289/ehp.9088251
Dates
Type When
Created 22 years, 3 months ago (May 9, 2003, 8:47 p.m.)
Deposited 1 year, 7 months ago (Jan. 16, 2024, 11:59 a.m.)
Indexed 2 months ago (July 1, 2025, 9:48 a.m.)
Issued 23 years, 3 months ago (May 28, 2002)
Published 23 years, 3 months ago (May 28, 2002)
Published Print 23 years, 3 months ago (May 28, 2002)
Funders 0

None

@article{Olashaw_2002, title={Paradigms of Growth Control: Relation to Cdk Activation}, volume={2002}, ISSN={1525-8882}, url={http://dx.doi.org/10.1126/stke.2002.134.re7}, DOI={10.1126/stke.2002.134.re7}, number={134}, journal={Science’s STKE}, publisher={American Association for the Advancement of Science (AAAS)}, author={Olashaw, Nancy and Pledger, W. J.}, year={2002}, month=may }